Metropolitan Life Insurance Company (MetLife)’s VeriSign VRSN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,554	Closed	-$674K	–	2062
2024 Q1	$674K	Sell	3,554 -62	-2%	-$12.2K	0.03%	420
2023 Q4	$745K	Sell	3,616 -97	-3%	-$20.2K	0.04%	378
2023 Q3	$752K	Sell	3,713 -233	-6%	-$48.4K	0.04%	352
2023 Q2	$892K	Sell	3,946 -151	-4%	-$33.3K	0.04%	340
2023 Q1	$866K	Sell	4,097 -1,131	-22%	-$233K	0.04%	347
2022 Q4	$1.07M	Sell	5,228 -236	-4%	-$45.2K	0.05%	348
2022 Q3	$949K	Sell	5,464 -181	-3%	-$33.5K	0.05%	363
2022 Q2	$945K	Sell	5,645 -222	-4%	-$40.7K	0.04%	381
2022 Q1	$1.31M	Sell	5,867 -5,095	-46%	-$1.11M	0.05%	350
2021 Q4	$2.78M	Sell	10,962 -422	-4%	-$97.6K	0.04%	390
2021 Q3	$2.33M	Sell	11,384 -567	-5%	-$124K	0.03%	437
2021 Q2	$2.72M	Sell	11,951 -3,407	-22%	-$742K	0.04%	391
2021 Q1	$3.05M	Sell	15,358 -944	-6%	-$185K	0.05%	346
2020 Q4	$3.53M	Sell	16,302 -834	-5%	-$171K	0.05%	291
2020 Q3	$3.51M	Sell	17,136 -786	-4%	-$162K	0.06%	261
2020 Q2	$3.71M	Sell	17,922 -826	-4%	-$171K	0.07%	234
2020 Q1	$3.38M	Sell	18,748 -217	-1%	-$42.7K	0.07%	235
2019 Q4	$3.65M	Sell	18,965 -123	-0.6%	-$23.1K	0.06%	291
2019 Q3	$3.6M	Sell	19,088 -1,485	-7%	-$305K	0.06%	272
2019 Q2	$4.3M	Buy	20,573 +1,007	+5%	+$198K	0.07%	234
2019 Q1	$3.55M	Sell	19,566 -1,086	-5%	-$186K	0.06%	252
2018 Q4	$3.06M	Sell	20,652 -202	-1%	-$30.3K	0.06%	260
2018 Q3	$3.34M	Buy	20,854 +889	+4%	+$136K	0.06%	280
2018 Q2	$2.74M	Buy	19,965 +3,232	+19%	+$414K	0.04%	359
2018 Q1	$1.98M	Sell	16,733 -79	-0.5%	-$9.15K	0.03%	536
2017 Q4	$1.92M	Sell	16,812 -27,665	-62%	-$3.09M	0.03%	572
2017 Q3	$4.73M	Sell	44,477 -1,722	-4%	-$173K	0.03%	610
2017 Q2	$4.29M	Sell	46,199 -1,614	-3%	-$146K	0.03%	663
2017 Q1	$4.17M	Sell	47,813 -1,572	-3%	-$131K	0.03%	688
2016 Q4	$3.76M	Sell	49,385 -2,308	-4%	-$182K	0.03%	720
2016 Q3	$4.04M	Sell	51,693 -1,900	-4%	-$152K	0.03%	656
2016 Q2	$4.63M	Sell	53,593 -1,154	-2%	-$99.5K	0.03%	563
2016 Q1	$4.85M	Sell	54,747 -2,055	-4%	-$168K	0.04%	530
2015 Q4	$4.96M	Sell	56,802 -1,569	-3%	-$131K	0.04%	495
2015 Q3	$4.12M	Sell	58,371 -3,547	-6%	-$242K	0.03%	590
2015 Q2	$3.82M	Sell	61,918 -308	-0.5%	-$19.8K	0.03%	678
2015 Q1	$4.17M	Sell	62,226 -2,760	-4%	-$168K	0.03%	609
2014 Q4	$3.7M	Sell	64,986 -2,746	-4%	-$159K	0.03%	686
2014 Q3	$3.73M	Sell	67,732 -7,026	-9%	-$379K	0.03%	652
2014 Q2	$3.65M	Sell	74,758 -5,272	-7%	-$263K	0.03%	699
2014 Q1	$4.31M	Sell	80,030 -3,066	-4%	-$174K	0.03%	602
2013 Q4	$4.97M	Sell	83,096 -6,108	-7%	-$336K	0.03%	515
2013 Q3	$4.54M	Sell	89,204 -10,066	-10%	-$486K	0.03%	528
2013 Q2	$4.43M	Buy	+99,270	New	+$4.6M	0.04%	495

Other funds holding VRSN

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VRSN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of VeriSign (VRSN) in Q2 2024, closing a stake of 3,554 shares — an estimated $674K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VRSN in Q2 2013 and held it in 44 quarters. The position peaked at $4.97M in Q4 2013. 650 funds tracked by Wall St. Rank hold VRSN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining VeriSign position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,554 VeriSign shares in Q2 2024, an estimated $674K.
Metropolitan Life Insurance Company (MetLife) first reported a position in VeriSign in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s VeriSign position peaked at $4.97M in Q4 2013.
650 funds tracked by Wall St. Rank held VeriSign as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.